Partial Oral Therapy for Osteomyelitis and Endocarditis - Is It Time?
N Engl J Med
.
2019 Jan 31;380(5):487-489.
doi: 10.1056/NEJMe1817264.
Author
Helen W Boucher
1
Affiliation
1
From the Tufts Center for Integrated Management of Antimicrobial Resistance and Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center and Tufts University School of Medicine, Boston.
PMID:
30699312
DOI:
10.1056/NEJMe1817264
No abstract available
Publication types
Editorial
Comment
MeSH terms
Administration, Intravenous
Anti-Bacterial Agents*
Endocarditis
Humans
Osteomyelitis*
Substances
Anti-Bacterial Agents